ArticleAIDS research and therapy2026
Beyond HIV: investigating key drivers of metabolic syndrome in midlife women with HIV in the INSTI era.
Article in AIDS research and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe contribution of lifestyle factors compared with HIV infection and antiretroviral therapy (ART)-related determinants to Metabolic Syndrome (MetS) in Women with HIV (WWH) remains uncertain.
objectivesTo evaluate the prevalence and determinants of MetS in the era of Integrase Strand Transfer Inhibitors (INSTI).
designMonocentric retrospective cohort study.
methodsWe analyzed 297 WWH to assess the prevalence of MetS and its association with HIV-related and lifestyle factors.
resultsMetS was diagnosed in 80 women (26%). Those with MetS showed lower CD4 nadir, longer HIV and ART duration, and greater exposure to protease inhibitors and INSTI, but none were independently associated with MetS or its components. Notably, lifestyle-related factors showed relatively strong associations with the study outcomes: physical activity was protective (OR 0.10, 95% CI 0.02-0.44), whereas physically demanding work increased risk (OR 6.58, 95% CI 2.03-26.26).
conclusionsLifestyle-related factors appeared to show stronger associations with MetS risk compared to HIV-related variables, underscoring the importance of systematic lifestyle assessment and targeted interventions in women with HIV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.